Trackings by Country Report
RegDesk Platform · Data as of April 7, 2026
📊 Trackings Distribution by Country
🇺🇸 US Market Dominance
The US accounts for 12 of 23 trackings (52.2%). FDA pathway is top priority — indicates a mature submission pipeline.
🌍 EU Second Largest Market
EU holds 7 trackings (30.4%). USA + EU combined = 82.6% — focused on the two largest global regulatory jurisdictions.
⚠️ Emerging Markets — Low Coverage
Turkey (2), Saudi Arabia (1), Portugal (1) = only 17.4%. Low volume — clear pipeline expansion opportunity.
📈 Portfolio Concentration Risk
With 82.6% in just 2 jurisdictions, the portfolio is highly concentrated. Diversification toward APAC, LATAM, and MENA could support broader market access.
📋 Country Breakdown — Detail
| # | Country | Trackings | Share | Signal |
|---|---|---|---|---|
| 1 | United States | 12 | 52.2% | High Volume |
| 2 | European Union | 7 | 30.4% | Watch |
| 3 | Turkey | 2 | 8.7% | OK |
| 4 | Saudi Arabia | 1 | 4.3% | OK |
| 5 | Portugal | 1 | 4.3% | OK |
Trackings by Country Report · V.1 · Page 1 of 1
© RegDesk 2026. This report is for informational purposes only and does not constitute legal or regulatory advice. Regulatory requirements are subject to change; always verify with official sources or the RegDesk Platform.
© RegDesk 2026. This report is for informational purposes only and does not constitute legal or regulatory advice. Regulatory requirements are subject to change; always verify with official sources or the RegDesk Platform.